Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-of-1 trial of rosuvastatin-associated myalgia
ACTRN12616001168448Phase 4Active, not recruiting
- Sponsor
- The George Institute for Global Health
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rosuvastatin in hypercholesterolemia and dyslipidemia, sponsored by The George Institute for Global Health. Primary endpoint: Value of N-of-1 trials in determining statin-induced myalgia. Started Apr 2017; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on ACTRN12616001168448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001168448.